A clinical trial is being conducted to assess the effectiveness of a cholesterol lowering drug in the treatment of Parkinson's disease.
A study conducted on Japanese men and women found peanut consumption decreased the risk of cardiovascular disease and ischemic stroke.
Cholesterol produced by astrocytes in the brain is required for the production of amyloid-beta. The findings shed light on how and why amyloid-beta forms, and may explain why genes associated with cholesterol have been implicated as risk factors for Alzheimer's disease.
Study in rats reveals sex differences may play a key role in the effectiveness of exercise as an appetite regulator. Exercising female rats ate more than those who did not partake in physical activity. The same effect was not seen in males.
Cholesterol synthesis in nerve cells ensures the replenishment of newly myelin-forming cells. The findings could provide new treatment options for the treatment of disorders associated with myelin loss, such as multiple sclerosis.
DIPG cancer cells exposed to MI-2 fail to maintain healthy levels of cholesterol and die quickly, by inhibiting lanosterol synthase. Additionally, while MI-2 destroys glioma cancer cells, the drug does not damage healthy brain cells.
Low HDL and high triglyceride levels in the blood at 35 were associated with an increased risk of developing Alzheimer's disease later in life. Additionally, higher glucose levels between 51 and 60 were linked to a higher risk of Alzheimer's.
Depriving glioblastoma brain cancer cells of cholesterol caused tumor regression and prolonged survival in mouse models of the disease, a new study reports.
Children born with high levels of triglycerides and low-density lipoprotein in their cord blood samples were more likely to receive lower ratings from their teachers on both social and emotional development scales.